ES2017258A6 - Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma. - Google Patents

Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma.

Info

Publication number
ES2017258A6
ES2017258A6 ES8902106A ES8902106A ES2017258A6 ES 2017258 A6 ES2017258 A6 ES 2017258A6 ES 8902106 A ES8902106 A ES 8902106A ES 8902106 A ES8902106 A ES 8902106A ES 2017258 A6 ES2017258 A6 ES 2017258A6
Authority
ES
Spain
Prior art keywords
peptides
proteins
vaccine formulations
vaccine against
melanoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES8902106A
Other languages
English (en)
Inventor
Joseph P Brown
Gregory Plowman
Karl E Hellstrom
Anthony Purchio
Sridhar Pennathur
Charles D Estin
Timothy M Rose
Hellstrom
Shiu-Lok Hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26676698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2017258(A6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/007,230 external-priority patent/US5262177A/en
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of ES2017258A6 publication Critical patent/ES2017258A6/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UN METODO PARA PRODUCIR PEPTIDOS ANTIGENICOS PARA VACUNAS RELACIONADOS CON EL ANTIGENO P97 ASOCIADO A MELANOMA, QUE CONTIENE UNA SECUENCIA DE AMINOACIDOS O CUALQUIER PORCION ANTIGENICA DE LA MISMA, CUYO METODO CONSISTE EN (I) COMBINAR UN GRUPO AMINO FIJADO AL CARBONO ALFA DE UN PRIMER AMINOACIDO; (II) ELIMINAR EL GRUPO PROTECTOR UNIDO AL GRUPO AMINO FIJADO AL CARBONO ALFA DEL AMINOACIDO TGERMINAL; (III) COMBINAR EL GRUPO AMINO DEL AMINOACIDO TERMINAL LIBERADO EN LA ETAPA (II) CON UN GRUPO CARBOXILO FIJADO AL CARBONO ALFA DE UN AMINOACIDO; Y (IV) REPETIR LAS ETAPAS (II) Y (III) HASTA QUE SE CONSIGUE UNA CADENA PEPTIDICA DE LA LONGITUD DESEADA.
ES8902106A 1986-02-07 1989-06-15 Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma. Expired - Fee Related ES2017258A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82731386A 1986-02-07 1986-02-07
US07/007,230 US5262177A (en) 1986-02-07 1987-01-27 Recombinant viruses encoding the human melanoma-associated antigen

Publications (1)

Publication Number Publication Date
ES2017258A6 true ES2017258A6 (es) 1991-01-16

Family

ID=26676698

Family Applications (2)

Application Number Title Priority Date Filing Date
ES8700288A Expired - Fee Related ES2012815A6 (es) 1986-02-07 1987-02-06 Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma, y para preparar vacunas que los contienen.
ES8902106A Expired - Fee Related ES2017258A6 (es) 1986-02-07 1989-06-15 Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES8700288A Expired - Fee Related ES2012815A6 (es) 1986-02-07 1987-02-06 Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma, y para preparar vacunas que los contienen.

Country Status (18)

Country Link
JP (3) JP2664673B2 (es)
BE (1) BE1000175A3 (es)
CH (1) CH675424A5 (es)
DE (1) DE3703702C2 (es)
DK (1) DK63287A (es)
ES (2) ES2012815A6 (es)
FI (1) FI94836C (es)
GR (1) GR870195B (es)
HU (1) HU209144B (es)
IE (1) IE59597B1 (es)
IT (1) IT1222359B (es)
MX (1) MX9203574A (es)
NL (1) NL8700285A (es)
NO (1) NO178931C (es)
NZ (1) NZ219192A (es)
OA (1) OA08478A (es)
PT (1) PT84255B (es)
SE (2) SE506024C2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821925A1 (de) * 1998-05-15 1999-11-18 Roehnisch Tim Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien
JP4414023B2 (ja) * 1999-08-05 2010-02-10 オリエンタル酵母工業株式会社 関節炎関連メラノトランスフェリンの測定方法および試薬
JP4708027B2 (ja) * 2002-10-01 2011-06-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗癌組成物および抗感染疾患組成物ならびにこれらを使用する方法
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer

Also Published As

Publication number Publication date
SE8700466L (sv) 1987-08-08
DE3703702C2 (de) 1997-07-10
FI870501L (fi) 1987-08-08
DE3703702A1 (de) 1988-02-18
JPH09135692A (ja) 1997-05-27
HUT43107A (en) 1987-09-28
JPS62294698A (ja) 1987-12-22
NO870475D0 (no) 1987-02-06
PT84255A (en) 1987-03-01
OA08478A (fr) 1988-07-29
CH675424A5 (en) 1990-09-28
SE9202934D0 (sv) 1992-10-07
IT1222359B (it) 1990-09-05
NO178931C (no) 1996-07-03
DK63287D0 (da) 1987-02-06
SE8700466D0 (sv) 1987-02-06
DK63287A (da) 1987-08-08
JPH08280390A (ja) 1996-10-29
NZ219192A (en) 1991-10-25
NO178931B (no) 1996-03-25
PT84255B (pt) 1989-11-30
SE506024C2 (sv) 1997-11-03
JP2664673B2 (ja) 1997-10-15
FI94836B (fi) 1995-07-31
NL8700285A (nl) 1987-09-01
GR870195B (en) 1987-06-10
FI870501A0 (fi) 1987-02-06
BE1000175A3 (fr) 1988-07-12
IE59597B1 (en) 1994-03-09
NO870475L (no) 1987-08-10
IT8719291A0 (it) 1987-02-06
FI94836C (fi) 1995-11-10
HU209144B (en) 1994-03-28
ES2012815A6 (es) 1990-04-16
IE870319L (en) 1987-08-07
MX9203574A (es) 1992-07-01

Similar Documents

Publication Publication Date Title
UA42089C2 (uk) Протигрипозна вакцина на основі поверхневого антигену, спосіб її виробництва
DE58906121D1 (de) Rekombinantes Vaccinia-Virus MVA.
DK0584348T3 (da) Genetisk vaccine mod immundefektvirusser
HU9500571D0 (en) Retro-, inverso-, and retro-inverso synthetic peptide analogues
EE9900343A (et) Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon
GB2303854B (en) Helicobacter proteins and vaccines
FI102382B1 (fi) Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten
EA199800272A1 (ru) Фактор, стимулирующий дендритные клетки
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
DE69737413D1 (en) Bakterioferritin aus helicobacter pylori
ATE101200T1 (de) Impfstoffe gegen menschliche respiratorische viren.
HUP9901035A2 (hu) Idegen DNS-t tartalmazó parapoxvírusok, előállításuk és alkalmazásuk vakcinákban
ATE73349T1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
KR890700030A (ko) 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
ES2012815A6 (es) Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma, y para preparar vacunas que los contienen.
AU5573196A (en) A pluripotent vaccine against enveloped viruses
ZA941853B (en) Stimulation of immune response by viral protein
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
AR248047A1 (es) Procedimiento para la preparacion de una vacuna a base de virus del herpes bovina modificado tipo 1.
Huang et al. Synthetic peptides for the microbiologist.
RU92004487A (ru) Днк, полипептид, вакцина, вектор, микроорганизм, клетка насекомого, реагент, способы лечения и профилактики, способ обнаружения антигенов
ES8801958A1 (es) Un procedimiento para la determinacion de virus de sida
WO2002078621A3 (en) Replication-competent recombinant virus and methods of use thereof

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20110614